V014-1625 Screening compound: 5-benzyl-N-(2-methoxyethyl)-N-[3-(morpholin-4-yl)-3-oxopropyl]-4-oxo-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepine-2-carboxamide

V014-1625 Screening compound: 5-benzyl-N-(2-methoxyethyl)-N-[3-(morpholin-4-yl)-3-oxopropyl]-4-oxo-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepine-2-carboxamide
V014-1625 Screening compound: 5-benzyl-N-(2-methoxyethyl)-N-[3-(morpholin-4-yl)-3-oxopropyl]-4-oxo-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepine-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V014-1625
5-benzyl-N-(2-methoxyethyl)-N-[3-(morpholin-4-yl)-3-oxopropyl]-4-oxo-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepine-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V014-1625

Molecular Formula

C25H33N5O5 (C25 H33 N5 O5)

Compound Name

5-benzyl-N-(2-methoxyethyl)-N-[3-(morpholin-4-yl)-3-oxopropyl]-4-oxo-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepine-2-carboxamide

IUPAC name

5-benzyl-N-(2-methoxyethyl)-N-[3-(morpholin-4-yl)-3-oxopropyl]-4-oxo-4H5H6H7H8H-pyrazolo[15-a][14]diazepine-2-carboxamide

SMILES

COCCN(CCC(N1CCOCC1)=O)C(c1nn(CCCN(Cc2ccccc2)C2=O)c2c1)=O

InChI

InChI=1S/C25H33N5O5/c1-34-15-12-28(11-8-23(31)27-13-16-35-17-14-27)24(32)21-18-22-25(33)29(9-5-10-30(22)26-21)19-20-6-3-2-4-7-20/h2-4,6-7,18H,5,8-17,19H2,1H3

InChI Key

VSLQYAURXMODKC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19907485

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

483.57

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

0.071

Distribution Coefficient, logD

0.071

Water Solubility, LogSw

-1.48

Polar Surface Area

79.193

Acid Dissociation Constant (pKa)

24.02

Base Dissociation Constant (pKb)

-1.82

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

52.00

V014-1625 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with V014-1625 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V014-1625?
Check Price and Availability of V014-1625, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V014-1625 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V014-1625
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V014-1625
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V014-1625 available by request